Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Markers of Response to Pemetrexed (Companion Study to RC0524)

NCT00898820 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00898820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Markers of Response to Pemetrexed (Companion Study to RC0524)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2007
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer